2024-10-07 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**1. Performance vs. S&P 500:**

CVS Health Corp (CVS) has significantly underperformed the S&P 500 (VOO) with a cumulative return of -30.2% compared to 133.14% for the S&P 500. This represents a substantial difference of -163.34%, placing it at the 2.39 percentile of its historical performance relative to the S&P 500.

**2. Recent Price Action:**

* **Closing price:** 64.59
* **5-day moving average:** 62.83
* **20-day moving average:** 59.22
* **60-day moving average:** 58.76

CVS is currently trading above its 5-day, 20-day, and 60-day moving averages, indicating potential short-term upward momentum.

**3. Technical Indicators:**

* **RSI:** 75.7
* **PPO:** 1.07
* **Delta_Previous_Relative_Divergence:** -4.78 (Short-term downtrend)
* **Expected Return:** 0.0% (5-year expected return over S&P 500)

The RSI suggests CVS is in overbought territory, while the PPO indicates a positive momentum. However, the negative Delta_Previous_Relative_Divergence suggests a short-term downtrend. The expected return of 0.0% indicates a lack of expected outperformance against the S&P 500.

**4. Recent Earnings and Outlook:**

CVS's most recent earnings report for the quarter ending August 07, 2024, showed EPS of 1.83, exceeding the estimated EPS of 1.73. This indicates a positive earnings beat, showcasing the company's ability to outperform expectations. 

| Date         | EPS  | Expected EPS |
|--------------|------|--------------|
| 2024-08-07   | 1.83 | 1.73          |
| 2024-05-01   | 1.31 | 1.7           |
| 2024-02-07   | 2.12 | 2.01          |
| 2023-11-01   | 2.21 | 2.13          |
| 2023-08-02   | 2.21 | 2.12          |

**5. News & Recent Issues:**

* **Recent Market Outlook:** 
    * CVS's stock performance has been volatile in recent months, influenced by factors like healthcare policy changes and economic uncertainties.
    * Despite the recent earnings beat, analysts remain cautious about CVS's long-term prospects due to its heavy reliance on the pharmacy business and potential challenges from the rising cost of prescription drugs.
    * FINBOLD analysts see CVS as a "hold" with potential for future growth, but with caution due to current market conditions.
* **Analyst Opinions:** 
    * Analyst opinions vary, with some expressing optimistic outlooks based on CVS's robust pharmacy business, while others are more cautious due to competitive pressures and potential regulatory changes.
* **Performance Highlights:** 
    * CVS has been investing in digital platforms and expanding its healthcare services, which could contribute to future growth.
    * The company has also focused on cost-cutting measures to improve profitability.

**6. Overall Analysis:**

CVS Health Corp (CVS) exhibits a mixed outlook. While the stock has underperformed the S&P 500 significantly, recent positive earnings results and a strong pharmacy business show potential for improvement. However, technical indicators suggest a short-term downtrend, and analysts remain cautious about long-term prospects due to market uncertainties. Investors should carefully consider these factors before making any investment decisions.

**7. **CVS Health Corp (CVS) is a leading healthcare company that provides pharmacy, health insurance, and other healthcare services.